Skip to main content

Table 1 Baseline characteristics of subjects according to the low-density lipoprotein cholesterol (LDL-C) levels

From: Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease

 

LDL-C1

< 70 mg/dL

LDL-C2

70–99

LDL-C3

100–129

LDL-C4

130–159

LDL-C5

≥ 160 mg/dL

N

224,131

522,912

630,875

409,247

218,035

Baseline LDL-C (mg/dL)

55.1 ± 11.9

85.9 ± 8.5

114.2 ± 8.6

142.7 ± 8.5

182.1 ± 21.3

Age (years)

59.1 ± 10.3

58.9 ± 10.5

58.3 ± 10.6

57.9 ± 10.6

57.8 ± 10.4

Sex (male)

149,064 (66.5)

323,164 (61.8)

378,583 (60.0)

224,922 (55.0)

100,376 (46.0)

Body mass index (kg/m2)

24.8 ± 3.3

24.9 ± 3.3

25.0 ± 3.3

25.2 ± 3.2

25.3 ± 3.2

Systolic BP (mmHg)

128.7 ± 15.6

128.5 ± 15.5

128.9 ± 15.6

129.4 ± 15.7

130.1 ± 16.1

Diastolic BP (mmHg)

78.5 ± 10.1

78.5 ± 10.1

79.0 ± 10.0

79.5 ± 10.1

80.0 ± 10.2

Fasting glucose (mg/dL)

139.1 ± 42.5

140.1 ± 41.6

143.5 ± 41.9

146.9 ± 43.1

151.5 ± 46.4

eGFR (mL/min/1.73 m2)

85.9 ± 36.2

85.6 ± 35.5

85.5 ± 34.5

85.1 ± 34.3

84.3 ± 33.8

Baseline TC (mg/dL)

142.1 ± 22.5

168.4 ± 20.1

196.2 ± 19.1

225.3 ± 18.7

266.8 ± 27.9

Baseline HDL-C (mg/dL)

51.7 ± 15.7

51.3 ± 13.6

51.4 ± 12.8

51.8 ± 12.4

53.0 ± 12.4

Baseline TG (mg/dL)

150.5 (150.1–150.8)

136.7 (136.5–136.9)

136.9 (136.7–137.0)

140.0 (139.8–140.2)

146.1 (145.8–146.4)

Current smoker

64,610 (28.8)

132,128 (25.3)

154,612 (24.5)

95,907 (23.4)

46,259 (21.2)

Alcohol drinking

27,933 (12.5)

48,397 (9.3)

51,235 (8.1)

28,894 (7.1)

12,738 (5.8)

Regular exercise

109,775 (49.0)

256,835 (49.1)

307,824 (48.8)

195,661 (47.8)

98,948 (45.4)

Income (lower 25%)

51,468 (23.0)

117,938 (22.6)

142,292 (22.6)

92,628(22.6)

50,908(23.4)

Hypertension

145,727 (65.0)

311,176 (59.5)

346,790 (55.0)

215,537(52.7)

113,059(51.9)

On statin treatment

123,580(55.1)

199,393 (38.1)

144,862 (23.0)

95,709(23.4)

81,496(37.4)

Duration of diabetes (years)

9.2 ± 5.5

8.6 ± 5.7

7.7 ± 5.8

7.1 ± 5.7

6.5 ± 5.4

Use of aspirin

117,987 (52.6)

245,124 (46.9)

254,625 (40.4)

149,627(36.6)

75,142(34.5)

  1. Data are expressed as the mean ± SD, median (25–75%), or n (%)
  2. BP, blood pressure; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglyceride
  3. P-values for the trend were < 0.0001 for all variables because of the large size of the study population